South & Central America Opioids Market Forecast to 2030 - Regional Analysis - by Product, Application, Route of Administration, and Distribution Channel

List of Tables

The South & Central America opioids market was valued at US$ 478.28 million in 2022 and is expected to reach US$ 584.07 million by 2030; it is estimated to register a CAGR of 2.5% from 2022 to 2030.

Increasing Geriatric Population Fuel South & Central America Opioids Market

The majority of older people live with chronic pain, resulting in reduced strength to carry out their daily routine. The geriatric population widely suffers from bone and joint disorders, arthritis, cancer, and other chronic disorders causing pain. According to the World Health Organization (WHO) data from February 2018, the geriatric population is estimated to grow by 22% by 2050 compared with 12% in 2015. The data also stated that low- and middle-income countries would account for nearly 80% of this surge. A number of developed countries are also experiencing significant growth in the geriatric population, which is driven by improved healthcare facilities and better healthcare services; this has resulted in increased life expectancy in these regions. An aging population drives the opioid market primarily through increased demand for pain management solutions. Additionally, older adults often undergo surgeries and medical procedures that necessitate pain management. Thus, the growing geriatric population across the region drives the growth of the opioids market.

South & Central America Opioids Market Overview

According to the data from the Pan American Health Organization (PAHO), more than 30 million people in Brazil are aged 60 and above, representing 13% of the country's population. By 2030, this count is expected to reach ~50 million, representing 24% of the Brazilian population. As per the Brazilian Institute of Geography and Statistics, the country's population aged 65 and above is expected to hold a 36% share of the total population of Brazil by 2050. Chronic pain is one of the most common conditions affecting older adults. People suffering from this condition prefer using opioid products, leading to increased opioid prescriptions.

According to The Brazilian Health Regulatory Agency (ANVISA) and Brazilian private hospital systems Brazil was severely affected by the onset of the COVID-19 pandemic, with 700,000 deaths as of April 2022. The health conditions of its citizens were worsened by delays in vaccine availability, leading to high rates of hospitalization and ventilation for severe cases that accelerated the demand for fentanyl, used as a sedative during intubation, according to The Brazilian Health Regulatory Agency (ANVISA) and Brazilian private hospital systems.

Further, according to data published in The Lancet Regional Health-Americas in April 2023, there has been an increase in prescription opioid use in Brazil in the past two decades, including for medical and non-medical purposes, which is driving the market in Brazil.

South & Central America Opioids Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Opioids Market Segmentation

The South & Central America opioids market is categorized into product, application, route of administration, distribution channel, and country.

Based on product, the South & Central America opioids market is segmented immediate release short acting opioid and extended release long acting opioid. The immediate release short acting opioid segment held a larger market share in 2022. The immediate release short acting opioid is further sub segmented into oxycodone, hydrocodone, tramadol, codeine, propoxyphene, and others. The extended release long acting opioid is further sub segmented into oxycodone, fentanyl, morphine, methadone, and others.

In terms of application, the South & Central America opioids market is categorized into pain management, anesthesia, diarrhea suppression, cough suppression, de-addiction, and others. The pain management segment held the largest market share in 2022.

By route of administration, the South & Central America opioids market is segmented into oral, injectable, and transdermal patch. The oral segment held the largest market share in 2022.

By distribution channel, the South & Central America opioids market is bifurcated into hospital pharmacies and retail pharmacies. The hospital pharmacies segment held a larger market share in 2022.

By country, the South & Central America opioids market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America opioids market share in 2022.

Endo International plc, Mallinckrodt Plc, Neuraxpharm Pharmaceuticals SL, Rusan Pharma Ltd, and Teva Pharmaceutical Industries Ltd are some of the leading companies operating in the South & Central America opioids market.

Product Code: BMIRE00031031

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Opioids Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Surging Chronic Pain Incidence
- 4.1.2 Increasing Geriatric Population
4.2 Market Restraints
- 4.2.1 Increasing Drug Abuse
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives by Market Players
4.4 Impact of Drivers and Restraints:

5. Opioids Market - South & Central America Analysis

5.1 South & Central America Opioids Market Revenue (US$ Million), 2020-2030
5.2 South & Central America Opioids Market Forecast Analysis

6. South & Central America Opioids Market Analysis - by Product

6.1 Immediate Release Short Acting Opioid
- 6.1.1 Overview
- 6.1.2 Immediate Release Short Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.1.2.1 South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
6.2 Extended Release Long-Acting Opioid
- 6.2.1 Overview
- 6.2.2 Extended Release Long-Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.2.2.1 South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

7. South & Central America Opioids Market Analysis - by Application

7.1 Pain Management
- 7.1.1 Overview
- 7.1.2 Pain Management: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Anesthesia
- 7.2.1 Overview
- 7.2.2 Anesthesia: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Diarrhea Suppression
- 7.3.1 Overview
- 7.3.2 Diarrhea Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cough Suppression
- 7.4.1 Overview
- 7.4.2 Cough Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 De-Addiction
- 7.5.1 Overview
- 7.5.2 De-Addiction: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Opioids Market Analysis - by Route of Administration

8.1 Oral
- 8.1.1 Overview
- 8.1.2 Oral: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Injectable
- 8.2.1 Overview
- 8.2.2 Injectable: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Transdermal Patch
- 8.3.1 Overview
- 8.3.2 Transdermal Patch: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Opioids Market Analysis - by Distribution Channel

9.1 Hospital Pharmacies
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Retail Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Opioids Market - Country Analysis

10.1 South & Central America
- 10.1.1 South & Central America Opioids Market, by Key Countries - Revenue (2022) (US$ Million)
- 10.1.2 South & Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
  - 10.1.2.1 South & Central America: Opioids Market - Revenue and Forecast Analysis - by Country
  - 10.1.2.2 Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.1 Brazil: South & Central America Opioids Market Breakdown, by Product
    - 10.1.2.2.2 Brazil: South & Central America Opioids Market Breakdown, by Immediate Release Short Acting Opioid
    - 10.1.2.2.3 Brazil: South & Central America Opioids Market Breakdown, by Extended Release Long Acting Opioid
    - 10.1.2.2.4 Brazil: South & Central America Opioids Market Breakdown, by Application
    - 10.1.2.2.5 Brazil: South & Central America Opioids Market Breakdown, by Route of Administration
    - 10.1.2.2.6 Brazil: South & Central America Opioids Market Breakdown, by Distribution Channel
  - 10.1.2.3 Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.1 Argentina: South & Central America Opioids Market Breakdown, by Product
    - 10.1.2.3.2 Argentina: South & Central America Opioids Market Breakdown, by Immediate Release Short Acting Opioid
    - 10.1.2.3.3 Argentina: South & Central America Opioids Market Breakdown, by Extended Release Long-Acting Opioid
    - 10.1.2.3.4 Argentina: South & Central America Opioids Market Breakdown, by Application
    - 10.1.2.3.5 Argentina: South & Central America Opioids Market Breakdown, by Route of Administration
    - 10.1.2.3.6 Argentina: South & Central America Opioids Market Breakdown, by Distribution Channel
  - 10.1.2.4 Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.4.1 Rest of South & Central America: Opioids Market Breakdown, by Product
    - 10.1.2.4.2 Rest of South & Central America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
    - 10.1.2.4.3 Rest of South & Central America: Opioids Market Breakdown, by Extended Release Long Acting Opioid
    - 10.1.2.4.4 Rest of South & Central America: Opioids Market Breakdown, by Application
    - 10.1.2.4.5 Rest of South & Central America: Opioids Market Breakdown, by Route of Administration
    - 10.1.2.4.6 Rest of South & Central America: Opioids Market Breakdown, by Distribution Channel

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Opioids Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Endo International plc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Mallinckrodt Plc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Neuraxpharm Pharmaceuticals SL
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Rusan Pharma Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms